HHV 2 Screening

Herpes Simplex Virus Type 2 primarily affects the genital area and is transmitted by physical contact. However, cross-infection may result from orogenital intercourse. While generally not dangerous, it is a nuisance, can be painful and may be emotionally traumatic. While there is no cure, the frequency and severity of attacks can be reduced.

The Purpose of HHV-2 Screening

The purpose of screening for Genital Herpes is to identify infected patients and help them recognize symptoms, reduce transmission to others, and protect themselves from acquiring HIV and other STDs. Screening the people also helps to identify uninfected patients and helps them protect themselves from acquiring genital herpes and other STDs. The following screening recommendations are based on currently available evidence and expert opinion. Patient education and client-centered risk-reduction counseling should always be provided in conjunction with HSV serologic screening.

Screening in Patients at Risk for STD/HIV

Individuals with multiple partners and high-risk physical behavior are at increased risk of acquiring and transmitting HSV-2. If a provider identifies a patient as being at risk for STD/HIV and is motivated to reduce his or her physical risk behavior, the provider should offer HSV-2 serology testing as an adjunct to counseling to facilitate risk reduction. Recommendations for how frequently patients who test negative for HSV-2 should be screened have not yet been established.

Screening in HIV-infected Patients

Asymptomatic HSV-2 infections in HIV-infected individuals may be associated with increased transmission of HIV and may accelerate the course of HIV disease. Thus, providers should offer to screen for HIV-infected patients who do not have a history of genital herpes. If previously unidentified symptoms are uncovered with screening, HSV suppressive therapy may be offered for symptom management. Although the subject of ongoing clinical trials, there is currently no direct evidence that HSV antiviral suppression will decrease HIV transmission. In addition to the risk-reduction counseling that should be offered to all HIV-infected patients, HSV-specific education and counseling also should be provided. HIV-infected patients who are HSV-2 negative have a high risk of HSV-2 acquisition. Recommendations regarding the frequency of repeat testing for those who test negative have not yet been developed; however, testing should be considered with the acquisition of STDs or high-risk behaviors.

Screening of Patients in Relationships or Considering Relationships With HSV-2-Infected Individuals

Individuals in HSV-serodiscordant relationships are at high risk of HSV transmission. To inform patients’ physical decision-making, providers should offer to screen patients whose partners or potential partners have a history of genital herpes or known HSV- 2 infection. Serologic testing would be useful if results indicating discordance motivate couples to take measures to prevent transmission. Recommendations regarding the frequency of repeat testing for those who test negative have not yet been established. However, testing should be considered if genital symptoms develop, prior to entry into a new partnership, and for seronegative women when pregnant. HSV-2- infected patients should be educated about the risk of transmission in future partnerships, pregnancy risks, and risk of HIV acquisition.

Screening in Pregnancy

Neonatal herpes, although rare, is one of the most serious complications of herpes infection. Unfortunately, there is no evidence that screening women to identify at-risk pregnancies (serologically negative pregnant women with HSV-infected partners) will lead to a reduction in neonatal herpes. Therefore, universal screening should not be offered to pregnant women. Among women with existing HSV infection, maternal antibodies passed to the neonate are usually protective against infection at birth. Because there are no known safe and effective interventions to prevent neonatal transmission when lesions are absent at delivery, screening to identify pregnant women with asymptomatic herpes infections is not recommended. All pregnant women should be asked about their own and their partners’ history of genital (and oral) herpes and examined for evidence of active herpes lesions at delivery. Providers should offer to screen asymptomatic pregnant women whose partners have genital herpes, as well as HIV-infected pregnant women. Serodiscordant couples (serologically negative pregnant women with HSV-infected partners) should be educated regarding the risk of acquiring and transmitting herpes and transmission to their newborns. Specific advice should be to avoid sex or to use condoms consistently in the third trimester. Women who have a history of herpes or seroconvert before delivery have a very low risk of transmitting herpes to their newborns. These women should be educated about their low risk of neonatal herpes and that cesarean section does not reduce risk except when they have symptoms around the time of delivery. Antiviral suppression has been shown to decrease the rate of cesarean sections.

Screening in the General Population

Universal HSV-2 screening of sexually active patients is not recommended because there is limited evidence that either risk-reduction counseling or antiviral medication will significantly decrease HSV transmission in the general population.

Education and Counseling Herpes education and prevention counseling is necessary for all patients being tested or screened for HSV-2. In pre-test counseling, the provider can determine patient preparedness for the diagnosis, as well as motivation to reduce risk behavior. Post-test counseling can provide support and reassurance to patients testing positive, as well as educate them about the natural history of the disease and its transmissibility. Those identified as uninfected should be informed about how to prevent future acquisition of herpes and other STDs.

Also View

Screening of HHV 2 The purpose of screening for Genital Herpes is to identify infected patients and help them recognize symptoms, reduce transmission to others, and protect themselves from acquiring HIV and other STDs.

Genital Herpes An infection of herpes simplex virus type 2 (HSV2) can lead to genital herpes, a sexually transmitted disease that causes blisters and pain in the genital area. Most of the people who are infected with HSV-2 have no symptoms of disease or do not recognize their symptoms

Herpes Treatment – A beautiful melange of time-tested resonance homeopathic medicines and homotoxological remedies so as to stimulate the immune system to heal itself following nature’s laws.

Types of Human Herpes Virus

After reviewing the following data you are now in a position to make an informed decision. We hope you make the right choice and we will be with you on your journey to recovery. Please get in contact with any of our Doctors if you need any further information.

To regain your life and freedom CLICK HERE!

All our products are made in FDA compliant GMP certified Laboratories in Germany, Switzerland, USA, India, and Spain. They are appropriately registered with the FDA as Dietary supplements, Homeopathic attenuations or Ayurvedic herbs. Utmost care is taken to ensure optimum quality and purity. Biogetica is a website visited from across the globe. Some countries consider Ayurveda, TCM, Supplements, Bioenergetics and Homeopathy to be medicine, while others do not. In order to comply with various FDA norms of numerous nations we say:

Ayurveda & Homeopathy may or may not qualify as medicine in your home jurisdiction. The complementary advice of our practitioners who are considered Homeopathic and Ayurvedic Doctors in some jurisdictions does not replace the medical advice given by your primary care physician. Biogetica’s Homeopathic products may be used for treatment of self limiting over the counter ailments in USA, India & Europe that support Homeopathy for OTC use. Biogetica’s Herbal remedies from the Ayurvedic, Chinese and other traditions may only be used to balance the 5 elements and rejuvenate organ systems in countries where Herbs, Ayurveda and TCM are not considered medicine. Biogetica’s ground breaking supplements may only be used to support the ideal structure and function of the various systems in the Human Body.

Information provided on this website has not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease.

Information provided on this website has not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease.

* This peer reviewed and published research has most probably not been studied or approved by the FDA in your country as a treatment or cure. Hence no disease claims can be made and you are welcome to take the natural ingredients for (immunity, lung health, cardiovascular health, etc). Homeopathy is medicine in USA but only for OTC issues. Ayurveda is medicine only in India and TCM is medicine only in China. Switzerland supports insurance payments for Homeopathy.

As per the FTC Enforcement Policy Statement on Marketing Claims for OTC Homeopathic drugs anyone selling homeopathy must state.

There is insufficient scientific evidence that homeopathy works, and

The product’s claims are based only on theories of homeopathy from the 1700s that are not accepted by most modern medical experts.

** Our remedies have been traditionally used in Ayurveda and Homeopathy for centuries. Each remedy has a varying amount of modern research behind it. We, in abiding by the law make no claims of a miracle cure or permanent results. Individual results may vary from individual to individual.

*** Try our Products Now! Our Unconditional 100 % Money Back Guarantee is Valid for 90 days.

† All Homeopathic products are made in accordance with the Homeopathic Pharmacopoeia of the United States, a document which has been published for over 100 years and which is recognized as an “official compendium” by Sections 501(b) and 502(e)(3) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 351(b) and 352(e)(3) (“FD&C Act”).” These indications are based solely on traditional homeopathic use. They have not been evaluated by the Food & Drug Administration.

†† These testimonials are unsolicited and unedited except for the name of the sender. They contain the senders’ initials or first name only for purposes of privacy. These are actual emails from many we were able to help over the years. Testimonials represent a cross section of the range of outcomes that appear to be typical with these products. Your results may vary. We do however stand by our products and will refund you completely if our products don’t meet your expectations.

What we do is simply point you and your Doctors to independent research from all sources that we know of, on the ingredients or entire formulation of our natural products, which are Herbal, Ayurvedic, Bioenergetic, Homeopathic and Complementary in nature. We invite you to read these studies on our clinical trials page or on scholar.google.com. Results may vary from person to person as is depicted in the wide range of results seen in the clinical trials.

0
0
Your Cart
Your cart is empty
Apply Coupon
Please Use Coupon code "bloom" for 18% off today!
USD